Abstract:Objective In multicellular organisms, cell communication allows multiple cells to coordinate with each other and involved in various important biological processes, and the abnormal cell communication pattern have also been demonstrated to be associated with many diseases. In the past decades, the rapid development of single-cell RNA sequencing technology makes it possible to study cell communication pattern through constructing cell communication network based on inferring ligand-receptor interactions, and many methods have been proposed. However, most of them only consider the expression of ligands and receptors to quantify the cell-cell interaction strength, but ignore the effect of specific receptor to its downstream gene regulatory network which reflects whether that receptor participates in particular biological process or not. To fill this gap, we propose a novel method (named IRRG) to construct cell communication networks at cell type level. Methods Our IRRG algorithm consists of the following three main steps. (1) IRRG uses the signaling pathway database to construct the gene regulatory network for each receptor in each cell type, and then calculates receptor impact score (RIS) for each receptor based on a random walk algorithm. RIS represents the degree of receptor impacts on downstream genes during cell communication. (2) IRRG uses permutation test to identify ligand-receptor pairs with significant specificity across cell types in order to discover more biologically significant cellular communication phenomena. (3) IRRG combined ligand-receptor co-expression with RIS to calculate the strength of all ligand-receptor interactions between cell types, and then constructed cellular communication networks. Results To validate the effectiveness of our IRRG, we construct cell communication networks of mouse epidermal tissue and human kidney cancer tissue separately. For mouse interfollicular epidermis (IFE) dataset, IRRG constructs biologically meaningful cellular communication networks, reasonably infers the different roles played by cells at different levels of epidermal tissue in cooperation, and discovers ligand-receptor pairs that are closely related to epidermal physiological processes. We also verified the robustness of the IRRG calculated receptor impact score, indicating that the IRRG calculated receptor impact score can reasonably reflect the signaling of cellular communication processes. By counting the supporting literature possessed of the top ranked ligand-receptor pairs, we also indirectly verified that the cell communication network constructed by IRRG is more reliable. In addition, we identify the cellular communication patterns of tumor tissues in clear cell renal cells (ccRCC) using IRRG and analyze how tumor cells influence normal cells to complete their own growth and development or migration process through cellular communication, further understanding the tumor microenvironment. Conclusion In this paper, we propose a novel method for constructing cellular communication networks named IRRG which integrating receptor-regulated gene expression information through random walk. Case studies on two datasets show that IRRG can construct biologically significant cellular communication networks, which can help us understand the mechanism of biological processes from the perspective of cellular communication. The source code and associated datasets used in this work are publicly available at https://github.com/NWPU-903PR/IRRG.

CellEnBoost: A boosting-based ligand-receptor interaction identification model for cell-to-cell communication inference

Analyses of Cell-to-cell Communication Combining a Heterogeneous Deep Ensemble Framework and Scoring Approaches from Single-Cell RNA Sequencing Data

SEnSCA: Identifying possible ligand‐receptor interactions and its application in cell–cell communication inference

Identifying Potential Ligand-Receptor Interactions Based on Gradient Boosted Neural Network and Interpretable Boosting Machine for Intercellular Communication Analysis

Deciphering ligand–receptor-mediated intercellular communication based on ensemble deep learning and the joint scoring strategy from single-cell transcriptomic data

Development of an Immunogenomics-Based Prognostic Index Model of Laryngeal Squamous Cell Carcinoma

CellDialog: A Computational Framework for Ligand-Receptor-Mediated Cell-Cell Communication Analysis

A novel CAF-cancer cell crosstalk-related gene prognostic index based on machine learning: prognostic significance and prediction of therapeutic response in head and neck squamous cell carcinoma

Cell-cell communication inference and analysis in the tumour microenvironments from single-cell transcriptomics: data resources and computational strategies

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.

Inferring Intercellular Communication and Intracellular Regulations from Single-Cell or Spatial Transcriptomics Data: A Systematic Survey and Benchmarking

ESICCC as a systematic computational framework for evaluation, selection, and integration of cell-cell communication inference methods

THGB: predicting ligand-receptor interactions by combining tree boosting and histogram-based gradient boosting

Cell-cell communication network-based interpretable machine learning predicts cancer patient response to immune checkpoint inhibitors

CellCall: integrating paired ligand–receptor and transcription factor activities for cell–cell communication

Identification of Cancer-Related Long Non-Coding RNAs Using XGBoost With High Accuracy

scCrab: A Reference-Guided Cancer Cell Identification Method based on Bayesian Neural Networks

collectNET: a web server for integrated inference of cell-cell communication network

DeepLION: Deep Multi-Instance Learning Improves the Prediction of Cancer-Associated T Cell Receptors for Accurate Cancer Detection.

Inference of Cell-cell Communication Networks by Integrating Receptor-regulated Gene Expression Information

Integrating Cell Interaction with Transcription Factors to Obtain a Robust Gene Panel for Prognostic Prediction and Therapies in Cholangiocarcinoma.